Mint Tower Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
Mint Tower Capital Management's DICE Position: Q3 2023 in Review
Mint Tower Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 16,189 shares — an estimated $752K sold.
Mint Tower Capital Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $752K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Mint Tower Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Mint Tower Capital Management sold 16,189 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $752K.
- Mint Tower Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
- Mint Tower Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $752K in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Mint Tower Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.